X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1793) 1793
Publication (84) 84
Book Review (37) 37
Book Chapter (15) 15
Book / eBook (1) 1
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1479) 1479
female (762) 762
male (760) 760
index medicus (623) 623
middle aged (560) 560
aged (493) 493
molecular-weight heparin (483) 483
anticoagulants - therapeutic use (455) 455
infusions, intravenous (438) 438
treatment outcome (427) 427
intravenous unfractionated heparin (402) 402
anticoagulants - administration & dosage (392) 392
heparin (388) 388
adult (364) 364
heparin - administration & dosage (357) 357
hematology (356) 356
deep-vein thrombosis (337) 337
cardiac & cardiovascular systems (332) 332
peripheral vascular disease (332) 332
unfractionated heparin (317) 317
heparin - therapeutic use (308) 308
injections, intravenous (302) 302
anticoagulants (292) 292
heparin, low-molecular-weight - therapeutic use (265) 265
medicine, general & internal (253) 253
anticoagulants - adverse effects (240) 240
venous thrombosis - drug therapy (216) 216
heparin - adverse effects (210) 210
fibrinolytic agents - therapeutic use (204) 204
initial treatment (203) 203
venous thrombosis (203) 203
risk factors (197) 197
thromboembolism (197) 197
therapy (194) 194
pharmacology & pharmacy (192) 192
pulmonary-embolism (192) 192
thrombosis (192) 192
heparin, low-molecular-weight - administration & dosage (189) 189
venous thromboembolism (187) 187
hemorrhage - chemically induced (178) 178
time factors (178) 178
dose-response relationship, drug (176) 176
injections, subcutaneous (174) 174
drug therapy (173) 173
animals (169) 169
pulmonary embolism (162) 162
aged, 80 and over (161) 161
partial thromboplastin time (155) 155
thrombolytic therapy (150) 150
fibrinolytic agents - administration & dosage (149) 149
care and treatment (146) 146
prospective studies (144) 144
enoxaparin (140) 140
anticoagulation (139) 139
surgery (138) 138
retrospective studies (134) 134
pulmonary embolism - drug therapy (129) 129
standard heparin (127) 127
acute disease (125) 125
drug administration schedule (125) 125
follow-up studies (124) 124
recurrence (124) 124
continuous intravenous heparin (119) 119
metaanalysis (119) 119
myocardial infarction - drug therapy (119) 119
heparin, low-molecular-weight - adverse effects (117) 117
percutaneous coronary intervention (117) 117
management (116) 116
randomized controlled trials as topic (114) 114
pregnancy (112) 112
abridged index medicus (111) 111
medicine & public health (111) 111
mortality (109) 109
prevention (109) 109
drug therapy, combination (107) 107
health aspects (106) 106
low molecular weight heparin (104) 104
acute myocardial-infarction (102) 102
cardiology (102) 102
subcutaneous heparin (102) 102
low-molecular-weight heparin (98) 98
thromboembolism - drug therapy (98) 98
administration, oral (97) 97
respiratory system (97) 97
enoxaparin - administration & dosage (96) 96
thrombolysis (96) 96
deep venous thrombosis (94) 94
acute coronary syndromes (93) 93
electrocardiography (93) 93
intravenous heparin (93) 93
pharmacokinetics (92) 92
randomized-trial (92) 92
safety (92) 92
aspirin (91) 91
trial (91) 91
unstable angina (91) 91
warfarin (90) 90
clinical trials as topic (89) 89
heart attacks (88) 88
risk (87) 87
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1721) 1721
German (34) 34
French (28) 28
Spanish (12) 12
Russian (9) 9
Polish (3) 3
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 11, pp. 997 - 1009
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9957, pp. 1849 - 1858
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2006, Volume 355, Issue 10, pp. 1006 - 1017
Journal Article
Pediatrics, ISSN 0031-4005, 03/2009, Volume 123, Issue 3, pp. e510 - e518
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 07/2003, Volume 108, Issue 2, pp. 135 - 142
Background-The combination of a single-bolus fibrinolytic and a low-molecular-weight heparin may facilitate prehospital reperfusion and further improve... 
Myocardial infarction | Reperfusion | Heparin | Fibrinolysis | Hemorrhage | MORTALITY | RETEPLASE | CARDIAC & CARDIOVASCULAR SYSTEMS | TISSUE-PLASMINOGEN ACTIVATOR | myocardial infarction | fibrinolysis | heparin | THERAPY | PERIPHERAL VASCULAR DISEASE | REOCCLUSION | reperfusion | INTERVENTION | hemorrhage | Injections, Intravenous | Humans | Middle Aged | Heparin - therapeutic use | Male | Risk | Tissue Plasminogen Activator - therapeutic use | Enoxaparin - therapeutic use | Heparin - adverse effects | Enoxaparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Time Factors | Hemorrhage - etiology | Injections, Subcutaneous | Thrombolytic Therapy - methods | Female | Safety | Drug Therapy, Combination | Treatment Outcome | Emergency Medical Services - statistics & numerical data | Myocardial Infarction - drug therapy | Survival Analysis | Aged | Emergency Medical Services - methods | Thrombolytic Therapy - adverse effects | Cohort Studies | Hemorrhage/etiology | Enoxaparin/adverse effects/therapeutic use | Injections; Intravenous | Emergency Medical Services/methods/statistics & numerical data | Myocardial Infarction/drug therapy | Injections; Subcutaneous | Thrombolytic Therapy/adverse effects/methods | Drug Therapy; Combination | Research Support; Non-U.S. Gov't | Heparin/adverse effects/therapeutic use | Tissue Plasminogen Activator/adverse effects/therapeutic use
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9792, pp. 693 - 703
Journal Article